Editas Medicine Inc. (EDIT)

Editas Medicine Inc. (EDIT $2.90)
- $2.90 Cap: $245M
- View EDIT Profile
- View Questions on EDIT

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Editas Medicine Inc. (EDIT $2.90)
- $2.90 Cap: $245M
- View EDIT Profile
- View Questions on EDIT

Q: Hello,
Why Editas stock go up today?
Thanks!

Read Answer Asked by Nancy on February 20, 2025

Illumina Inc. (ILMN $102.94)
- $102.94 Cap: $15.26B
- View ILMN Profile
- View Questions on ILMN
Telo Genomics Corp. (TELO)
- P/E (TTM): -21.9X Cap: $2M
- View TELO Profile
- View Questions on TELO
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
Editas Medicine Inc. (EDIT $2.90)
- $2.90 Cap: $245M
- View EDIT Profile
- View Questions on EDIT
CRISPR Therapeutics AG (CRSP $54.55)
- $54.55 Cap: $4.80B
- View CRSP Profile
- View Questions on CRSP
ARK Genomic Revolution ETF (ARKG $25.49)
- $25.49 P/E (TTM): 26.8X Cap: $973M
- View ARKG Profile
- View Questions on ARKG

Q: The genome space seems to have taken a hit and I'd like to add some to my portfolio. Can you give me 3 to 5 Canadian or US stocks going forward that you believe have the highest potential of gains( I realise this would also be subject to the most risk) for a 5 plus year hold.

Also 3 to 5 stocks from Canada or US that you feel should be held for long term exposure.

Thank you.

Read Answer Asked by Richard on August 19, 2021

Editas Medicine Inc. (EDIT $2.90)
- $2.90 Cap: $245M
- View EDIT Profile
- View Questions on EDIT
CRISPR Therapeutics AG (CRSP $54.55)
- $54.55 Cap: $4.80B
- View CRSP Profile
- View Questions on CRSP
Intellia Therapeutics Inc. (NTLA $10.54)
- $10.54 Cap: $1.08B
- View NTLA Profile
- View Questions on NTLA

Q: Hello,

I took a 1% position, total, in these 3 names about a year ago, as a speculative buy. They have all declined, rather significantly since my initial buy, making all 3 names less than 1% of my total portfolio. I have however noticed some recent relative strength. Would you move on or do you see this area as an interesting speculative buy? To note, I also own a 1.5% position in Illumina. Thanks as always

Read Answer Asked by Aaron on March 11, 2019